India’s Life Sciences & Healthcare (LSHC) Global Capability Center ecosystem is entering a defining decade. With nearly 60% of global LSHC GCC capacity anchored in India and market value projected to reach $100Bn by 2030, the opportunity ahead is structural – but execution will determine who leads. This whitepaper explores how India is transitioning from a cost-driven delivery hub to a global innovation engine through the lens of the Triple-T Turbine – Talent, Technology, and Transformation.
Drawing on ecosystem data, industry insights, and leadership perspectives, the report examines AI-led drug discovery, clinical analytics, digital regulatory platforms, distributed hub strategies, and emerging execution frictions. For enterprise leaders, investors, and GCC strategists, it offers a clear strategic playbook to move beyond scale, build differentiated capabilities, and win the decade of LSHC GCC growth in India.
What’s Driving India’s LSHC GCC Boom? Inside the Whitepaper Vision | Authors Explain
In this conversation on Healthark’s latest GCC whitepaper, “Winning the Decade of Life Sciences & Healthcare GCC Growth in India,” the authors – Ritu Baliya (Associate Director, Growth Advisory), Riya Doshi (Engagement Manager, Growth Advisory), and Sachin Baghadiya (Senior Consultant, Growth Advisory), break down the key ideas behind the report and how it shapes the future of GCCs in #India.